The DOI matches its Crossref record; 276 of the 277 references it cites were found in a registry or an index.
Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms
Open accessAbstract
Leukodystrophies are genetically determined disorders characterized by the selective involvement of the central nervous system white matter. Onset may be at any age, from prenatal life to senescence. Many leukodystrophies are degenerative in nature, but some only impair white matter function. The clinical course is mostly progressive, but may also be static or even improving with time. Progressive leukodystrophies are often fatal, and no curative treatment is known. The last decade has witnessed a tremendous increase in the number of defined leukodystrophies also owing to a diagnostic approach combining magnetic resonance imaging pattern recognition and next generation sequencing. Knowledge on white matter physiology and pathology has also dramatically built up. This led to the recognition that only few leukodystrophies are due to mutations in myelin- or oligodendrocyte-specific genes, and many are rather caused by defects in other white matter structural components, including astrocytes, microglia, axons and blood vessels. We here propose a novel classification of leukodystrophies that takes into account the primary involvement of any white matter component. Categories in this classification are the myelin disorders due to a primary defect in oligodendrocytes or myelin (hypomyelinating and demyelinating leukodystrophies, leukodystrophies with myelin vacuolization); astrocytopathies; leuko-axonopathies; microgliopathies; and leuko-vasculopathies. Following this classification, we illustrate the neuropathology and disease mechanisms of some leukodystrophies taken as example for each category. Some leukodystrophies fall into more than one category. Given the complex molecular and cellular interplay underlying white matter pathology, recognition of the cellular pathology behind a disease becomes crucial in addressing possible treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The astrocytic contribution of the TSPO signal could also complicate differentiation of multiple sclerosis from leukodystrophies that have significant astrocytic but not microglial involvement (van der Knaap and Bugiani, 2017).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as van der Knaap and Bugiani, 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Dynamic instability of microtubule growth
Mitchison, T., & Kirschner, M. (1984) · Nature · doi:10.1038/312237a0 · Cited by 3,337
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523
Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain
Gibson, E. M., Purger, D., Mount, C. W., Goldstein, A. K., Lin, G. L., Wood, L. S., Inema, I., Miller, S. E., Bieri, G., Zuchero, J. B., et al. (2014) · Science · doi:10.1126/science.1252304 · Cited by 1,472
Flagged first, then by citations
Research works printed but not linked: 6
- Agamanolis DP (2004) Pathology & genetics. Developmental neuropathology. ISN Neuropath, City
- Bielschowsky MH, Henneberg R (1928) Über familiäre diffuse Sklerose (Leukodystrophia cerebri progressiva hereditaria). J Psychol Neurol 36:131–181
- Pelizaeus F (1899) Überr eine eigenartige faimiliäre Entwicklungshemmung cornehmlich auf motorischem Gebiete. Archiv Psych 31:100
- Powers JM (2004) Peroxisomal disorders. In: Pathology & genetics. Developmental neuropathology. JA Golden, BN Harding (eds). ISN Neuropath Press, Basel. pp.287–295
- Suzuki K, Suzuki K (1996) The gangliosidoses. In: handbook of clinical neurology, RJ Vinken and GW Bruyn, Revised series Vol 22 (66) Neurodystrophies and neurolipidoses, HW Moser (ed) Elsevier Science B.V., Amsterdam, pp.247-280.
- Suzuki KV, Vanier M.T. (2004) Sphingolipidoses. In: Pathology & genetics. Developmental neuropathology. JA Golden, BN Arding (eds). ISN Neuropath, Basel. pp.235-236.
Cited by
Sorted by citations
Items 101–200 of 414
Janowska, J., Ziemka‐Nałęcz, M., & Sypecka, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020331 · Cited by 19
The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia
Sirkis, D. W., Bonham, L. W., & Yokoyama, J. S. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s245029 · Cited by 21
Leukodystrophy imaging: Insights for diagnostic dilemmas.
Thakkar, R. N., Patel, D., Kioutchoukova, I. P., Al-Bahou, R., Reddy, P., Foster, D. T., & Lucke-Wold, B. (2024) · Medical Sciences · doi:10.3390/medsci12010007 · Cited by 17
Homozygous UBA5 Variant Leads to Hypomyelination with Thalamic Involvement and Axonal Neuropathy
Al‐Saady, M. L., Kaiser, C. S., Wakasuqui, F., Korenke, G. C., Waisfisz, Q., Polstra, A. M., Pouwels, P. J. W., Bugiani, M., van der Knaap, M. S., Lunsing, R. J., et al. (2021) · Neuropediatrics · doi:10.1055/s-0041-1724130 · Cited by 17
Self-citationThe neurovascular unit in leukodystrophies: towards solving the puzzle
Zarekiani, P., Pinto, H. N., Hol, E. M., Bugiani, M., & de Vries, H. E. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00316-0 · Cited by 18
Self-citationFeng, L., Chao, J., Zhang, M., Pacquing, E., Hu, W., & Shi, Y. (2023) · iScience · doi:10.1016/j.isci.2023.108037 · Cited by 17
Brügger, M., Lauri, A., Zhen, Y., Gramegna, L. L., Zott, B., Sekulić, N., Fasano, G., Kopajtich, R., Cordeddu, V., Radio, F. C., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.02.005 · Cited by 17
Differential Diagnosis of Pediatric Multiple Sclerosis
Galardi, M. M., Gaudioso, C., Ahmadi, S., Evans, E. M., Gilbert, L. A., & Mar, S. (2019) · Children · doi:10.3390/children6060075 · Cited by 18
Recent Advancements in the Diagnosis and Treatment of Leukodystrophies
Bradbury, A. M., & Ream, M. A. (2021) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2021.100876 · Cited by 17
Kaur, P., do Rosario, M. C., Hebbar, M., Sharma, S., Kausthubham, N., Nair, K. V., Aroor, S., Ramesh Bhat, Y., Lewis, L. E. S., Nampoothiri, S., et al. (2021) · Clinical Genetics · doi:10.1111/cge.14037 · Cited by 17
Bianchin, M. M., & Snow, Z. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.032 · Cited by 17
Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.
Metovic, J., Li, Y., Gong, Y., & Eichler, F. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00443 · Cited by 16
Pathology of the neurovascular unit in leukodystrophies
Zarekiani, P., Breur, M., Wolf, N. I., de Vries, H. E., van der Knaap, M. S., & Bugiani, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01206-6 · Cited by 16
Self-citationAssociation of Rare Variants in ARSA with Parkinson's Disease
Senkevich, K. A., Beletskaia, M., Dworkind, A., Yu, E., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., Fahn, S., Waters, C., et al. (2023) · Movement Disorders · doi:10.1002/mds.29521 · Cited by 16
Development of perivascular astrocyte processes
Cohen‐Salmon, M., Guille, N., & Boulay, A.-C. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1585340 · Cited by 17
Dynamic Lamin B1-Gene Association During Oligodendrocyte Progenitor Differentiation
Yattah, C., Hernandez, M., Huang, D., Park, H., Liao, W., & Casaccia, P. (2020) · Neurochemical Research · doi:10.1007/s11064-019-02941-y · Cited by 16
Joyal, K., Michaud, J., van der Knaap, M. S., Bugiani, M., & Venkateswaran, S. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly105 · Cited by 16
Self-citationPan, J., Forés-Martos, J., Nouh, C. D., Jensen, T. D., Vallejo, K., Cayrol, R., Ahmadian, S. S., Ashley, E. A., Greicius, M. D., & Cobos, I. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01853-5 · Cited by 16
Novel mutations in the GJC2 gene associated with Pelizaeus–Merzbacher-like disease
Owczarek‐Lipska, M., Mulahasanovic, L., Obermaier, C. D., Hörtnagel, K., Neubauer, B. A., Korenke, G. C., Biskup, S., & Neidhardt, J. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04906-4 · Cited by 15
The multicellular interplay of microglia in health and disease: lessons from leukodystrophy
Berdowski, W. M., Sanderson, L. E., & van Ham, T. J. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048925 · Cited by 15
Lanciotti, A., Brignone, M. S., Macioce, P., Visentin, S., & Ambrosini, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010274 · Cited by 14
Neri, I., Ramazzotti, G., Mongiorgi, S., Rusciano, I., Bugiani, M., Conti, L., Cousin, M. A., Giorgio, E., Padiath, Q. S., Vaula, G., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03461-1 · Cited by 14
Self-citationEarly evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV
Mepyans, M. E., Andrzejczuk, L., Sosa, J., Smith, S., Herron, S., DeRosa, S., Slaugenhaupt, S., Misko, A. L., Grishchuk, Y., & Kiselyov, K. I. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.044230 · Cited by 16
Knuutinen, O. A., Oikarainen, J. H., Suo-Palosaari, M. H., Kangas, S. M., Rahikkala, E., Pokka, T. M.-L., Moilanen, J. S., Hinttala, R., Vieira, P., & Uusimaa, J. (2021) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14884 · Cited by 14
Solving the hypomyelination conundrum - Imaging perspectives
Malik, P., Muthusamy, K., Mankad, K., Shroff, M. M., & Sudhakar, S. V. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.04.007 · Cited by 14
Gene and Cellular Therapies for Leukodystrophies
Aerts‐Kaya, F., & van Til, N. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112522 · Cited by 14
Fernandes, M. G. F., Pernin, F., Antel, J. P., & Kennedy, T. E. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16219 · Cited by 13
Xie, J., Wang, N., Wei, Q., Ma, H., Bai, G., Shen, Y., & Wu, Z. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13284 · Cited by 13
A recurrent de novo HSPD1 variant is associated with hypomyelinating leukodystrophyPreprint
Cömert, C., Brick, L., Ang, D., Palmfeldt, J., Meaney, B. F., Kozenko, M., Georgopoulos, C. P., Guerra, P. F., & Bross, P. (2020) · Molecular Case Studies · doi:10.1101/mcs.a004879 · Cited by 13
Basic Microglial Functions and How They Go Awry in Neurodegenerative Disease
McKinney, J. E., Bennett, M. L., & Bennett, F. C. (2026) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042624-114332 · Cited by 13
A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy
Antony, J. S., Daniel-Moreno, A., Lamsfus‐Calle, A., Raju, J., Kaftancioglu, M., Ureña-Bailén, G., Rottenberger, J., Hou, Y., Santhanakumaran, V., Lee, J.-H., et al. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0075 · Cited by 12
DEGS1-related leukodystrophy: a clinical report and review of literature
Wong, M. S. T., Thomas, T. G. S., Lim, J. Y., Kam, S., Teo, J. X., Ching, J., Goh, C. Y. J., Jamuar, S. S., Lim, W. K., & Koh, A. L. (2023) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000457 · Cited by 12
Regional vulnerability of brain white matter in vanishing white matter
Man, J. H. K., van Gelder, C. A. G. H., Breur, M., Molenaar, D., Abbink, T. E. M., Altelaar, M. A. F., Bugiani, M., & van der Knaap, M. S. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01599-6 · Cited by 12
Self-citationCd59 and inflammation regulate Schwann cell development
Wiltbank, A. T., Steinson, E. R., Criswell, S. J., Piller, M., & Kucenas, S. (2022) · eLife · doi:10.7554/elife.76640 · Cited by 12
Urbik, V. M., Schmiedel, M., Soderholm, H. E., & Bonkowsky, J. L. (2020) · Child Neurology Open · doi:10.1177/2329048x20939003 · Cited by 12
Hematopoietic stem cell transplantation in leukodystrophies
Sevin, C., & Mochel, F. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00017-x · Cited by 12
Quantitative MRI distinguishes different leukodystrophies and correlates with clinical measures
Stellingwerff, M. D., Al‐Saady, M. L., Chan, K., Dvorak, A. V., Marques, J. P., Kolind, S., Schoenmakers, D. H., van Voorst, R. J., Roosendaal, S. D., Barkhof, F., et al. (2024) · European Radiology · doi:10.1007/s00330-024-11089-5 · Cited by 11
The natural history of variable subtypes in pediatric-onset TUBB4A-related leukodystrophy
Gavazzi, F., Charsar, B. A., Hamilton, E. M. C., Erler, J. A., Patel, V., Woidill, S., Sevagamoorthy, A., Helman, G., Schmidt, J., Pizzino, A. M., et al. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109048 · Cited by 11
Yamamoto, T., Yamamoto‐Shimojima, K., Ueda, Y., Imai, K., Takahashi, Y., Imagawa, E., Miyake, N., & Matsumoto, N. (2018) · Human Genome Variation · doi:10.1038/s41439-018-0020-z · Cited by 11
The Role of Extracellular Vesicles in Demyelination of the Central Nervous System
López‐Guerrero, J. A., Ripa, I., Andreu, S., & Bello‐Morales, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239111 · Cited by 11
Cortical Pathology in Vanishing White Matter
Man, J. H. K., van Gelder, C. A. G. H., Breur, M., Okkes, D., Molenaar, D., van der Sluis, S., Abbink, T. E. M., Altelaar, M. A. F., van der Knaap, M. S., & Bugiani, M. (2022) · Cells · doi:10.3390/cells11223581 · Cited by 11
Self-citationKhan, D., Ramachandiran, I., Vasu, K. I., China, A., Khan, K., Cumbo, F., Halawani, D., Terenzi, F., Zin, I., Long, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48549-x · Cited by 11
Unusual white matter involvement in EAST syndrome associated with novel KCNJ10 mutations
Severino, M., Lualdi, S., Fiorillo, C., Striano, P., Toni, T. D., Peluso, S., Michele, G. D., Rossi, A., Filocamo, M., & Bruno, C. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8826-7 · Cited by 11
Emerging Concepts in Vector Development for Glial Gene Therapy: Implications for Leukodystrophies
von Jonquières, G., Rae, C. D., & Housley, G. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661857 · Cited by 12
Sejda, A., Wierzba‐Bobrowicz, T., Adamek, D., Gulczyński, J., Michalak, S., Grajkowska, W., & Iżycka‐Świeszewska, E. (2021) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2021.0088 · Cited by 10
Septins in the nervous system: from cytoskeletal dynamics to neurological disorders
Alkhanjari, R. R., Alhajeri, M. M., Bhamidimarri, P. M., Alhosani, K. M., Kashir, J., Torii, T., & Hamdan, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02430-6 · Cited by 10
Gupta, S. S., Schwab, M., Valdez-Gonzalez, K., & Segal, E. B. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.103970 · Cited by 10
Jorge, M. S., & Bugiani, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_9 · Cited by 11
Self-citationTransmembrane topology and oligomeric nature of an astrocytic membrane protein, MLC1
Hwang, J., Park, K., Lee, G.-Y., Yoon, B. Y., Kim, H., Roh, S. H., Lee, B., Kim, K., & Lim, H. (2021) · Open Biology · doi:10.1098/rsob.210103 · Cited by 10
Park, W. U., Yeon, G., Yu, M., Goo, H., Hwang, S.-H., Na, D., & Kim, D. (2021) · Biology · doi:10.3390/biology10121254 · Cited by 10
Ataei, Z., Nouri, Z. H. M., Tavakoli, F., Pourreza, M. R., Narrei, S., & Tabatabaiefar, M. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282304 · Cited by 10
Lok, H. C., & Kwok, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052541 · Cited by 10
Case report: ‘AARS2 leukodystrophy’
Axelsen, T. M., Vammen, T. L., Bak, M., Pourhadi, N., Stenør, C., & Grønborg, S. W. (2021) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2021.100782 · Cited by 10
Böck, D., Revers, I. M., Bomhof, A. S. J., Hillen, A. E. J., Boeijink, C., Kissling, L., Egli, S., Moreno-Mateos, M. A., van der Knaap, M. S., van Til, N. P., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.009 · Cited by 9
Pathologic and Therapeutic Schwann Cells
Shurin, M. R., Wheeler, S., Zhong, H. M., & Zhou, Y. (2025) · Cells · doi:10.3390/cells14171336 · Cited by 9
Wang, J., Chen, S., Zhang, H., Wang, M., Zhu, J., & Zhang, X. (2019) · Brain and Behavior · doi:10.1002/brb3.1313 · Cited by 9
Derksen, A., Shih, H., Forget, D., Darbelli, L., Tran, L. T., Poitras, C., Guerrero, K., Tharun, S., Alkuraya, F. S., Kurdi, W., et al. (2021) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2021.100034 · Cited by 9
Zerem, A., Ben‐Sira, L., Vigdorovich, N., Leibovitz, Z., Fisher, Y., Schiffmann, R., Grishchuk, Y., Misko, A. L., Orenstein, N., Lev, D., et al. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00742-3 · Cited by 9
Helman, G., Zerem, A., Almad, A., Hacker, J. L., Woidill, S., Sase, S., LeFevre, A. N., Ekstein, J., Johansson, M. M., Stutterd, C., et al. (2021) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2021.04.014 · Cited by 9
Hereditary spastic paraplegia and prominent sensorial involvement: think MAG mutations!
Roubertie, A., Charif, M., Meyer, P., Manès, G., Meunier, I., Taïeb, G., Morales, R. J., Guichet, A., Delettre, C., Sarzi, E., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50860 · Cited by 9
Khorrami, M., Khorram, E., Yaghini, O., Rezaei, M., Hejazifar, A., Iravani, O., Yazdani, V., Riahinezhad, M., & Kheirollahi, M. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01810-0 · Cited by 9
Opening New Horizons in the Treatment of Childhood Onset Leukodystrophies
Schiller, S. A., Henneke, M., & Gärtner, J. (2019) · Neuropediatrics · doi:10.1055/s-0039-1685529 · Cited by 9
Helman, G., Viaene, A. N., Takanohashi, A., Breur, M., Berger, R. S., Woidill, S., Cottrell, J. R., Schiffmann, R., Crow, Y. J., Simons, C., et al. (2020) · Journal of Child Neurology · doi:10.1177/0883073820958330 · Cited by 8
Self-citationWang, M., Wu, C., & Zhang, Z. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11760-9 · Cited by 8
Hardt, R., Dehghani, A., Schoor, C., Gödderz, M. P. O., Winter, N. C., Ahmadi, S., Sharma, R. K., Schork, K., Eisenacher, M., Gieselmann, V., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04892-8 · Cited by 8
Singh, N., & Singh, A. K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128780 · Cited by 8
Ramakrishnan, S., Arshad, F., Bs, K., Pon, A. G., Bosco, S., Kumar, S., Chidambaram, H., Chinnathambi, S. C. B., Kulanthaivelu, K., Arunachal, G., et al. (2024) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000538145 · Cited by 8
Microbiota gut-brain axis: implications for pediatric-onset leukodystrophies
Vaia, Y., Bruschi, F., Tagi, V. M., Tosi, M., Montanari, C., Zuccotti, G., Tonduti, D., & Verduci, E. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1417981 · Cited by 9
A fatal alliance: Glial connexins, myelin pathology and mental disorders
Zlomuzica, A., Plank, L., Kodzaga, I., & Dere, E. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.01.008 · Cited by 8
Gilani, A., Hove, J. L. K. V., Thomas, J. A., & Kleinschmidt-DeMasters, B. K. (2019) · Pediatric and Developmental Pathology · doi:10.1177/1093526619876448 · Cited by 8
Leukodystrophies — much more than just diseases of myelin
van der Knaap, M. S., & Bugiani, M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0093-9 · Cited by 8
Self-citationGarrison, S. R., Siegel, I. J., Takala, C. R., Vaithilingam, S. L., Yang, G. W., Zoghbi, A. W., Hartig, M. M., Vadapalli, S., & Anderson, M. L. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03941-8 · Cited by 7
Pediaditakis, I., Tsakali, S., Lemieux, M. R., Brennan, M., Robinson, W. H., Papapetropoulos, S., & Papapetropoulos, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100118 · Cited by 8
Cervical myelitis: a practical approach to its differential diagnosis on MR imaging
Weidauer, S., Hattingen, E., & Arendt, C. T. (2023) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-2114-1350 · Cited by 7
Rutherford, H. A., Candeias, D., Duncan, C. J. A., Renshaw, S. A., & Hamilton, N. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321496121 · Cited by 7
Overview of Neuro-Ophthalmic Findings in Leukodystrophies
Bettinger, C., Dulz, S., Atiskova, Y., Guerreiro, H., Schön, G., Guder, P., Maier, S. L., Denecke, J., & Bley, A. E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175114 · Cited by 7
Co-culture of Human Stem Cell Derived Neurons and Oligodendrocyte Progenitor Cells
Dooves, S., Nadadhur, A. G., Gasparotto, L., & Heine, V. M. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3350 · Cited by 7
The epileptology of Aicardi-Goutières syndrome: electro-clinical-radiological findings
GIORGIS, V. D., Varesio, C., Viri, M., Giordano, L., Piana, R. L., Tonduti, D., Roncarolo, F., Masnada, S., Pichiecchio, A., Veggiotti, P., et al. (2020) · Seizure · doi:10.1016/j.seizure.2020.11.019 · Cited by 7
Adult-onset leukodystrophy with vanishing white matter: a case series of 19 patients
Benzoni, C., Moscatelli, M. E. M., Farina, L., Magri, S., Ciano, C., Scaioli, V., Alverà, S., Cammarata, G., Bianchi‐Marzoli, S., Castellani, M., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11762-7 · Cited by 7
Stellingwerff, M. D., Al‐Saady, M. L., Chan, K., Dvorak, A. V., Marques, J. P., Kolind, S., Roosendaal, S. D., Wolf, N. I., Barkhof, F., van der Knaap, M. S., et al. (2023) · Journal of Neuroimaging · doi:10.1111/jon.13167 · Cited by 7
Hermanto, Y., Maki, T., Takagi, Y., Miyamoto, S., & Takahashi, J. B. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24413 · Cited by 8
Larsen, K. B., Bayat, A., Møller, R. S., Maroun, L. L., & Lund, E. L. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12557 · Cited by 7
Visual pathways evaluation in Kearns Sayre syndrome: a diffusion tensor imaging study
Rossi‐Espagnet, M. C., Lucignani, M., Pasquini, L., Napolitano, A., Stefano, P. R. O., Romano, A., Diodato, D., Martinelli, D., & Longo, D. (2019) · Neuroradiology · doi:10.1007/s00234-019-02302-0 · Cited by 7
Stem cell and gene therapies for leukodystrophies
Lin, W., Zhang, M., Zheng, S., & Lian, Q. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101527 · Cited by 7
Senthilvelan, S., Sekar, S., Kesavadas, C., & Thomas, B. (2021) · Clinical Neuroradiology · doi:10.1007/s00062-021-01030-4 · Cited by 6
Paprocka, J., Nowak, M., Machnikowska-Sokołowska, M. D., Rutkowska, K., & Płoski, R. (2024) · Genes · doi:10.3390/genes15030350 · Cited by 6
Biglari, S., Vahidnezhad, H., Tabatabaiefar, M. A., Khorshid, H. R. K., & Esmaeilzadeh, E. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2435 · Cited by 6
MRI pattern recognition in white matter disease
Wolf, N. I., Engelen, M., & van der Knaap, M. S. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00019-3 · Cited by 6
Lin, D., & Ho, C. (2024) · Cells · doi:10.3390/cells13221873 · Cited by 6
Mencacci, N. E., Minakaki, G., Maroofian, R., Pace, R. D., Paimboeuf, A., Fonseca, T. B., Abramova, T., Shannon, P., Chitayat, D. A., Magrinelli, F., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci195336 · Cited by 6
Cross-species efficacy of AAV-mediated ARSA replacement for metachromatic leukodystrophy
Ramachandran, S. S., Ardinger, J., Bu, J., Ramos, M., Guo, L., Ghosh, D., Hossain, M., Chou, S.-C., Chen, Y., Wischhof, E., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185001 · Cited by 6
Stutterd, C., Vanderver, A. L., Lockhart, P. J., Helman, G., Pope, K., Uebergang, E., Love, C., Delatycki, M. B., Thorburn, D. R., Mackay, M. T., et al. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104551 · Cited by 6
A hypomyelinating leukodystrophy in German Shepherd dogs
Quitt, P. R., Brühschwein, A., Matiasek, K., Wielaender, F., Karkamo, V., Hytönen, M. K., Meyer‐Lindenberg, A., Dengler, B., Leeb, T., Lohi, H., et al. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16085 · Cited by 6
Myelin-water imaging and multi-shell diffusion-weighted imaging in adults with adrenoleukodystrophy
Yska, H. A. F., Stellingwerff, M. D., Roosendaal, S. D., Voermans, M. M. C., van der Knaap, M. S., Pouwels, P. J. W., & Engelen, M. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf371 · Cited by 5
Curing the brain: in search for new astrocyte-specific therapies
Verkhratsky, A., Lee, C. J., Chun, H., Göritz, C., Harkany, T., Lee, J., Lee, S., Lindskog, M., Koh, W., Mulder, J., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01712-4 · Cited by 8
Brain MRI findings in paediatric genetic disorders associated with white matter abnormalities
Oikarainen, J. H., Knuutinen, O. A., Kangas, S. M., Rahikkala, E., Pokka, T. M.-L., Moilanen, J. S., Hinttala, R., Vieira, P., Uusimaa, J., & Suo-Palosaari, M. H. (2024) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.16036 · Cited by 5
Inherited white matter disorders: Hypomyelination (myelin disorders)
Perrier, S., Gauquelin, L., & Bernard, G. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00014-4 · Cited by 5
Expanding the Phenotype of NRROS ‐Related SENEBAC Syndrome
Srinivasan, V. M., Gowda, V. K., Markose, A. P., Kinhal, U. V., & Pandey, H. (2024) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63899 · Cited by 5
Stutterd, C., Kidd, A., Florkowski, C. M., Janus, E. D., Fanjul‐Fernández, M., Raizis, A. M., Wu, T. Y., Archer, J. S., Leventer, R. J., Amor, D. J., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62377 · Cited by 5
Coppo, L., Scheggi, S., DeMontis, G., Priora, R., Frosali, S., Margaritis, A., Summa, D., Giuseppe, D. D., Ulivelli, M., & Simplicio, P. D. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0269 · Cited by 5
Metadata
- Authors
- van der Knaap, M. S., & Bugiani, M.
- Affiliations
- Amsterdam Neuroscience (NL)
- Corresponding author
- Bugiani, Marianna
- Venue
- Acta Neuropathologica
- Published
- 2017-06-21
- Volume
- 134
- Issue
- 3
- Pages
- 351-382
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC5563342
- OpenAlex
- W2653495475
- Cited by
- 403
- References
- 276
- Citations by year
- 2026: 32 · 2025: 49 · 2024: 79 · 2023: 52 · 2022: 36 · 2021: 51 · 2020: 39 · 2019: 45 · 2018: 13 · 2017: 5
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Vrije Universiteit Amsterdam
- Fonds NutsOhra
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- leukodystrophy, white matter pathology, hypomyelinating leukodystrophy, astrocytopathy, oligodendrocytes, myelin disorders, neuropathology, disease mechanisms
- MeSH terms
- Axons, Demyelinating Diseases, Humans, Myelin Sheath, Neuroglia, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review